跳至主要内容
临床试验/NCT01624129
NCT01624129Unknown不适用

New Serological Markers for Eosinophilic Esophagitis

Technical University of Munich1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2011年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
20
试验地点
1

研究概览

简要总结

The purpose of the study is to investigate if serological parameters such as "extracellular Serum-Tryptase (ST)" and "eosinophilic cationic protein (ECP)" are useful for the diagnosis and surveillance of the eosinophilic esophagitis (EE).

详细描述

The eosinophilic esophagitis (EE) is chronic inflammatory and immunological disease. The diagnosis of EE is based upon large numbers of eosinophils in the esophagus on histopathologic examination (> 20 eosinophils per high powered field in at least one specimen) despite acid suppression with a Proton-Pump-Inhibitor (PPI) for at least two weeks.

There are no diagnostic serological markers for EE so far, so that the purpose of the study is to investigate serological markers which are established in other allergic diseases.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • histopathological defined eosinophilic esophagitis
  • Age: 18-80

排除标准

  • missing consent form
  • contraindications for performing esophagogastroscopy/taking biopsies of the esophagus

研究组 & 干预措施

eosinophilic esophagitis

patients with histopathological defined eosinophilic esophagitis

干预措施: Fluticasone (Drug)

研究者

发起方
Technical University of Munich
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验